Passive targeting (EPR effect): tumor blood vessels are irregular and leaky, with gaps up to a few hundred nanometres, while healthy vessels stay tightly sealed. A nanoparticle sized for that gap slips out into the tumor almost by accident — too small and it also leaks into healthy tissue; too large and it can't fit through either.
Active targeting: coating the particle with a ligand (e.g. an antibody) that binds a receptor over-expressed on tumor cells turns a passive leak into a durable dock, controlled by receptor density and ligand affinity.
- Blue = circulating in blood
- Green = bound to a tumor-cell receptor (delivered)
- Yellow = leaked into tumor tissue but not bound (may wash back)
- Grey = leaked into healthy tissue (side effect)